• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cervical cancer and the global health agenda: Insights from multiple policy-analysis frameworks.宫颈癌与全球卫生议程:多政策分析框架的见解。
Glob Public Health. 2013;8(10):1093-108. doi: 10.1080/17441692.2013.850524. Epub 2013 Nov 18.
2
Cervical cancer screening in low- and middle-income countries.低收入和中等收入国家的宫颈癌筛查
Mt Sinai J Med. 2011 May-Jun;78(3):319-26. doi: 10.1002/msj.20263.
3
Overview of cervical cancer in the developing world. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.发展中世界宫颈癌概述。国际妇产科联盟第26届妇科癌症治疗结果年度报告。
Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S205-10. doi: 10.1016/S0020-7292(06)60035-0.
4
[Costs of population cervical cancer screening program in Poland between 2007-2009].[2007 - 2009年波兰全国宫颈癌筛查项目的成本]
Ginekol Pol. 2010 Oct;81(10):750-6.
5
Clinical Controversies in Cervical Cancer Screening.宫颈癌筛查中的临床争议
Clin Obstet Gynecol. 2019 Dec;62(4):644-655. doi: 10.1097/GRF.0000000000000478.
6
Cost-effectiveness of cervical cancer prevention.子宫颈癌预防的成本效益
Clin Obstet Gynecol. 2013 Mar;56(1):55-64. doi: 10.1097/GRF.0b013e3182823797.
7
Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era.建立 HPV 疫苗接种后时代宫颈癌发病率和死亡率的筛查政策和筛查依从性影响模型。
J Public Health (Oxf). 2012 Dec;34(4):539-47. doi: 10.1093/pubmed/fds040. Epub 2012 Jun 15.
8
Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.泰国宫颈癌预防和控制政策选择的经济评价。
Pharmacoeconomics. 2011 Sep;29(9):781-806. doi: 10.2165/11586560-000000000-00000.
9
Executive summary.执行摘要。
Vaccine. 2012 Nov 20;30 Suppl 4:xi. doi: 10.1016/S0264-410X(12)01439-9.
10
The announcement by the GAVI Alliance Board to support human papillomavirus (HPV) vaccines in the world's poorest countries.全球疫苗免疫联盟董事会宣布在世界最贫困国家支持人乳头瘤病毒(HPV)疫苗。
Vaccine. 2012 Nov 20;30 Suppl 4:xii. doi: 10.1016/S0264-410X(12)01440-5.

引用本文的文献

1
The Expression of Programmed Cell Death Ligand-1 and its Relationship with Infiltration, Metastasis and Prognosis in Cervical Squamous Cell Carcinoma.程序性细胞死亡配体-1在宫颈鳞状细胞癌中的表达及其与浸润、转移和预后的关系
Reprod Sci. 2025 May;32(5):1676-1684. doi: 10.1007/s43032-024-01784-5. Epub 2025 Jan 30.
2
Why Was the Policy Idea on the Health Benefits Package Advisory Panel Gazetted in Kenya? A Retrospective Policy Analysis.为何肯尼亚要将健康福利套餐顾问小组政策提案刊登宪报?一项回溯性政策分析。
Int J Health Policy Manag. 2024;13:7608. doi: 10.34172/ijhpm.7608. Epub 2024 Jul 8.
3
Regaining policy attention for a health insurance capitation payment reform in Ghana: A prospective policy analysis.重新唤起加纳医疗保险按人头付费改革的政策关注:一项前瞻性政策分析。
PLOS Glob Public Health. 2024 May 30;4(5):e0003265. doi: 10.1371/journal.pgph.0003265. eCollection 2024.
4
Understanding the factors affecting global political priority for controlling sexually transmitted infections: a qualitative policy analysis.理解影响全球控制性传播感染政策优先级的因素:一项定性政策分析。
BMJ Glob Health. 2024 Jan 23;9(1):e014237. doi: 10.1136/bmjgh-2023-014237.
5
Civil society priorities for global health: concepts and measurement.民间社会在全球卫生中的优先事项:概念和衡量。
Health Policy Plan. 2023 Jun 16;38(6):708-718. doi: 10.1093/heapol/czad034.
6
WASH regulates the oxidative stress Nrf2/ARE pathway to inhibit proliferation and promote apoptosis of HeLa cells under the action of Jolkinolide B.WASH 通过调控氧化应激 Nrf2/ARE 通路抑制 Jolkinolide B 作用下的 HeLa 细胞增殖并促进其凋亡。
PeerJ. 2022 Jul 13;10:e13499. doi: 10.7717/peerj.13499. eCollection 2022.
7
The tension between national consistency and jurisdictional professional expansion: The case of pharmacist-administered vaccinations.国家一致性与司法管辖权专业扩张之间的紧张关系:以药剂师管理疫苗接种为例。
Res Social Adm Pharm. 2022 Oct;18(10):3782-3791. doi: 10.1016/j.sapharm.2022.04.008. Epub 2022 May 2.
8
MiRNA-873-5p Acts as a Potential Novel Biomarker and Promotes Cervical Cancer Progression by Regulating ZEB1 via Notch Signaling Pathway.微小RNA-873-5p作为一种潜在的新型生物标志物,通过Notch信号通路调控锌指E盒结合蛋白1促进宫颈癌进展。
Dose Response. 2021 Mar 11;19(1):15593258211001255. doi: 10.1177/15593258211001255. eCollection 2021 Jan-Mar.
9
Determinants of Mortality among Cervical Cancer Patients Attending in Tikur Anbessa Specialized Hospital, Ethiopia: Institutional-Based Retrospective Study.埃塞俄比亚提库尔安贝萨专科医院宫颈癌患者死亡率的决定因素:基于机构的回顾性研究
J Oncol. 2021 Jun 17;2021:9916050. doi: 10.1155/2021/9916050. eCollection 2021.
10
Why did Ghana's national health insurance capitation payment model fall off the policy agenda? A regional level policy analysis.为何加纳的国家医疗保险按人头付费模式从政策议程中消失了?一项区域层面的政策分析。
Health Policy Plan. 2021 Jun 25;36(6):869-880. doi: 10.1093/heapol/czab016.

本文引用的文献

1
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.《1975-2009 年全国癌症报告:人乳头瘤病毒(HPV)相关癌症的负担和趋势以及 HPV 疫苗接种覆盖率》
J Natl Cancer Inst. 2013 Feb 6;105(3):175-201. doi: 10.1093/jnci/djs491. Epub 2013 Jan 7.
2
A United Nations Global Health Panel for Global Health Governance.联合国全球卫生治理全球健康小组。
Soc Sci Med. 2013 Jan;76(1):12-5. doi: 10.1016/j.socscimed.2012.09.038. Epub 2012 Oct 18.
3
A framework convention on global health: health for all, justice for all.一个关于全球卫生的框架公约:人人健康,公平正义。
JAMA. 2012 May 16;307(19):2087-92. doi: 10.1001/jama.2012.4395.
4
Why does mental health not get the attention it deserves? An application of the Shiffman and Smith framework.为什么心理健康没有得到应有的重视?希夫曼和史密斯框架的应用。
PLoS Med. 2012 Feb;9(2):e1001178. doi: 10.1371/journal.pmed.1001178. Epub 2012 Feb 28.
5
Human papillomavirus vaccine and men: what are the obstacles and challenges?人乳头瘤病毒疫苗与男性:存在哪些障碍和挑战?
Curr Opin Infect Dis. 2012 Feb;25(1):86-91. doi: 10.1097/QCO.0b013e32834ed5be.
6
Building of the global movement for health equity: from Santiago to Rio and beyond.全球健康公平运动的建立:从圣地亚哥到里约热内卢及更远的地方。
Lancet. 2012 Jan 14;379(9811):181-8. doi: 10.1016/S0140-6736(11)61506-7. Epub 2011 Oct 18.
7
Global challenges of implementing human papillomavirus vaccines.人乳头瘤病毒疫苗实施的全球挑战。
Int J Equity Health. 2011 Jun 30;10:27. doi: 10.1186/1475-9276-10-27.
8
Priority actions for the non-communicable disease crisis.非传染性疾病危机的优先行动。
Lancet. 2011 Apr 23;377(9775):1438-47. doi: 10.1016/S0140-6736(11)60393-0. Epub 2011 Apr 5.
9
Reforming the World Health Organization.改革世界卫生组织。
JAMA. 2011 Apr 20;305(15):1585-6. doi: 10.1001/jama.2011.418. Epub 2011 Mar 29.
10
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.

宫颈癌与全球卫生议程:多政策分析框架的见解。

Cervical cancer and the global health agenda: Insights from multiple policy-analysis frameworks.

机构信息

a Department of Global Health and Development , London School of Hygiene and Tropical Medicine , London , UK.

出版信息

Glob Public Health. 2013;8(10):1093-108. doi: 10.1080/17441692.2013.850524. Epub 2013 Nov 18.

DOI:10.1080/17441692.2013.850524
PMID:24236409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3877944/
Abstract

Cervical cancer is the second leading cause of cancer deaths for women globally, with an estimated 88% of deaths occurring in the developing world. Available technologies have dramatically reduced mortality in high-income settings, yet cervical cancer receives considerably little attention on the global health policy landscape. The authors applied four policy-analysis frameworks to literature on global cervical cancer to explore the question of why cervical cancer may not be receiving the international attention it may otherwise warrant. Each framework explores the process of agenda setting and discerns factors that either facilitate or hinder policy change in cases where there is both a clear problem and a potential effective solution. In combination, these frameworks highlight a number of crucial elements that may be needed to raise the profile of cervical cancer on global health agendas, including improving local (national or sub-national) information on the condition; increasing mobilisation of affected civil society groups; framing cervical cancer debates in ways that build upon its classification as a non-communicable disease (NCD) and an issue of women's rights; linking cervical cancer screening to well-funded services such as those for HIV treatment in some countries; and identifying key global policy windows of opportunity to promote the cervical cancer agenda, including emerging NCD global health discussions and post-2015 reviews of the Millennium Development Goals.

摘要

宫颈癌是全球女性癌症死亡的第二大主要原因,据估计,发展中国家 88%的死亡病例由此导致。现有的技术已大大降低了高收入国家的死亡率,但宫颈癌在全球卫生政策领域几乎没有得到太多关注。作者将四个政策分析框架应用于全球宫颈癌文献,以探讨为什么宫颈癌可能没有得到它可能需要的国际关注。每个框架都探讨了议程设置的过程,并辨别了在存在明确问题和潜在有效解决方案的情况下,促进或阻碍政策变革的因素。这些框架结合起来,突出了一些可能需要的关键要素,以便在全球卫生议程中提高宫颈癌的地位,包括改善有关该疾病的当地(国家或国家以下一级)信息;增强受影响民间社会团体的动员;以将宫颈癌辩论建立在其被归类为非传染性疾病(NCD)和妇女权利问题的基础上;将宫颈癌筛查与资金充足的服务联系起来,如一些国家的艾滋病毒治疗服务;以及确定促进宫颈癌议程的关键全球政策机会窗口,包括新兴的非传染性疾病全球卫生讨论和 2015 年后千年发展目标审查。